Leveraging state cancer registries to measure and improve the quality of cancer care: a potential strategy for California and beyond.

Despite recent increased attention to healthcare performance and the burden of disease from cancer, measures of quality of cancer care are not readily available. In 2013, the California HealthCare Foundation convened an expert workgroup to explore the potential for leveraging data in the California Cancer Registry (CCR), one of the world's largest population-based cancer registries, for measuring and improving the quality of cancer care. The workgroup assessed current registry operations, the value to be gained by linking CCR data with health insurance claims or encounter data and clinical data contained in health system electronic health records, and potential barriers to these linkages. The workgroup concluded that: 1) The CCR mandate should be expanded to include use of its data for quality of cancer care measurement and public reporting; and 2) a system should be developed to support linkage of registry data with both claims data and provider electronic health record data.

[1]  Manisha Desai,et al.  Breast cancer treatment across health care systems: Linking electronic medical records and state registry data to enable outcomes research , 2014, Cancer.

[2]  K. Devers,et al.  Health services research and data linkages: issues, methods, and directions for the future. , 2010, Health services research.

[3]  M. Hendryx,et al.  Electronic patient registries improve diabetes care and clinical outcomes in rural community health centers. , 2009, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[4]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[5]  Robert S. Huckman,et al.  Public reporting, consumerism, and patient empowerment. , 2013, The New England journal of medicine.

[6]  F. Boscoe,et al.  Measuring colorectal cancer care quality for the publicly insured in New York State , 2012, Cancer medicine.

[7]  N. Howlader,et al.  Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer. , 2012, American journal of epidemiology.

[8]  A. Zaslavsky,et al.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Amar K. Das,et al.  Oncoshare: Lessons learned from building an integrated multi-institutional database for comparative effectiveness research , 2012, AMIA.

[10]  Peter Paul Yu,et al.  Lessons learned from the development of the CancerLinQ prototype: Clinical decision support. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Maureen A. Smith,et al.  Publicly reported quality-of-care measures influenced Wisconsin physician groups to improve performance. , 2013, Health affairs.

[12]  Martin T. Wells,et al.  The Charlson Comorbidity Index Can Be Used Prospectively to Identify Patients Who Will Incur High Future Costs , 2014, PloS one.

[13]  M. Talamonti,et al.  Cancer Recurrence: An Important but Missing Variable in National Cancer Registries , 2014, Annals of surgical oncology.

[14]  José Maria Paganni,et al.  Evaluating the quality of medical care. , 1966, The Milbank Memorial Fund quarterly.

[15]  K. Kahn,et al.  Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K W Kizer,et al.  Establishing health care performance standards in an era of consumerism. , 2001, JAMA.

[17]  J. Warren,et al.  Linking Tumor Registry and Medicaid Claims to Evaluate Cancer Care Delivery , 2009, Health care financing review.

[18]  Dhruv B. Sharma,et al.  Regional variation in spending and survival for older adults with advanced cancer. , 2013, Journal of the National Cancer Institute.

[19]  Judith H Hibbard,et al.  Does publicizing hospital performance stimulate quality improvement efforts? , 2003, Health affairs.

[20]  Scott L. DuVall,et al.  Evaluation of record linkage between a large healthcare provider and the Utah Population Database , 2012, J. Am. Medical Informatics Assoc..

[21]  F. Camacho,et al.  Cost impact of oral capecitabine compared to intravenous taxane-based chemotherapy in first-line metastatic breast cancer , 2009, Journal of medical economics.

[22]  Joseph Lipscomb,et al.  State-Level Cancer Quality Assessment and Research: Building and Sustaining the Data Infrastructure , 2011, Cancer journal.

[23]  T. Feeley,et al.  Improving cancer care through public reporting of meaningful quality measures. , 2011, Health affairs.

[24]  Sharyl J. Nass,et al.  Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis , 2014 .

[25]  American Society of Clinical Oncology National Census of Oncology Practices: preliminary report. , 2013, Journal of oncology practice.

[26]  Anil V Parwani,et al.  Challenges and opportunities in the adoption of College of American Pathologists checklists in electronic format: perspectives and experience of Reporting Pathology Protocols Project (RPP2) participant laboratories. , 2010, Archives of pathology & laboratory medicine.

[27]  A. Donabedian.  Evaluating the quality of medical care. 1966. , 1966, The Milbank quarterly.

[28]  S. Edge,et al.  Completeness of American Cancer Registry Treatment Data: implications for quality of care research. , 2013, Journal of the American College of Surgeons.

[29]  M. Talamonti,et al.  Cancer Recurrence: An Important but Missing Variable in National Cancer Registries , 2014, Annals of Surgical Oncology.